Patents by Inventor Soan Cheng

Patent number: 8524765
Abstract: Described herein are compounds and pharmaceutical compositions containing compounds of Formula (I), which modulate the activity of store-operated calcium (SOC) channels: wherein R1, R2 and R4 are defined herein. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.
Type: Grant
Filed: July 19, 2012
Issued: September 3, 2013
Assignee: Calcimedica, Inc.
Inventors: Gonul Velicelebi, Kenneth A. Stauderman, David P. M. Pleynet, Soan Cheng, Jeffrey P. Whitten
Application number: 20130165416
Abstract: The invention provides a novel compound having a structure corresponding to Formula (I): (A)-(B)—(C)-(D)??(I) or a pharmaceutically acceptable salt or prodrug thereof and methods for using them.
Type: Application
Filed: June 24, 2011
Issued: June 27, 2013
Inventors: Steven L. Wagner, Soan Cheng, William C. Mobley, Rudolph E. Tanzi
Application number: 20120289587
Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.
Type: Application
Filed: July 19, 2012
Issued: November 15, 2012
Assignee: CalciMedica, Inc.
Inventors: Gonul Velicelebi, Kenneth A. Stauderman, David P.M. Pleynet, Soan Cheng, Jeffrey P. Whitten
Patent number: 8263641
Abstract: Described herein are compounds of Formula I and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also describe herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity.
Type: Grant
Filed: August 15, 2008
Issued: September 11, 2012
Assignee: Calcimedica, Inc.
Inventors: Gonul Velicelebi, Kenneth A. Stauderman, David P. M. Pleynet, Soan Cheng, Jeffrey P. Whitten
Patent number: 8119680
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Grant
Filed: September 3, 2010
Issued: February 21, 2012
Assignee: Neurogenetic Pharmaceuticals, Inc.
Inventors: Soan Cheng, Daniel D Comer, Long Mao, Guity P Balow, David Pleynet
Patent number: 8017629
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Grant
Filed: August 23, 2010
Issued: September 13, 2011
Assignee: Neurogenetic Pharmaceuticals, Inc.
Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
Application number: 20100331551
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Application
Filed: September 3, 2010
Issued: December 30, 2010
Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
Application number: 20100324032
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Application
Filed: August 23, 2010
Issued: December 23, 2010
Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
Patent number: 7799808
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Grant
Filed: June 19, 2007
Issued: September 21, 2010
Assignee: Neurogenetic Pharmaceuticals, Inc.
Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
Patent number: 7781442
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Grant
Filed: July 17, 2007
Issued: August 24, 2010
Assignee: Neurogenetic Pharmaceuticals, Inc.
Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
Application number: 20070260058
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Application
Filed: July 17, 2007
Issued: November 8, 2007
Inventors: Soan Cheng, Daniel Comer, Long Mao, Guity Balow, David Pleynet
Application number: 20070249833
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Application
Filed: June 19, 2007
Issued: October 25, 2007
Inventors: Soan Cheng, Daniel Comer, Long Mao, Guity Balow, David Pleynet
Patent number: 7244739
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Grant
Filed: May 14, 2004
Issued: July 17, 2007
Assignee: Torreypines Therapeutics, Inc.
Inventors: Soan Cheng, Daniel D. Comer, Long Mao, Guity P. Balow, David Pleynet
Patent number: 6949669
Abstract: Compounds of general formula (I) wherein the substituents are as defined in claim 1 are suitable for use as herbicides
Type: Grant
Filed: January 23, 2001
Issued: September 27, 2005
Assignee: Syngenta Crop Protection, Inc.
Inventors: Gerald Wayne Craig, Martin Eberle, Martin Zeller, Steven Scott Bondy, Daniel Dennis Comer, Soan Cheng, Julie Elizabeth Penzotti, Peter Grootenhuis, Jürg Ehrler
Application number: 20050070538
Abstract: Novel compounds, compositions, and kits are provided. Methods of modulating A? levels, and methods of treating a disease associated with aberrant A? levels are also provided.
Type: Application
Filed: May 14, 2004
Issued: March 31, 2005
Inventors: Soan Cheng, Daniel Comer, Long Mao, Guity Balow, David Pleynet
Application number: 20040049065
Abstract: Compounds of general formula (I) wherein the substituents are as defined in claim 1 are suitable for use as herbicides.
Type: Application
Filed: October 18, 2002
Issued: March 11, 2004
Inventors: Gerald Wayne Craig, Martin Eberle, Martin Zeller, Steven Scott Bondy, Daniel Dennis Comer, Soan Cheng, Julie Elizabeth Penzotti, Peter Grootenhuis, Jurg Ehrler
Patent number: 6630485
Abstract: The present invention relates to compounds of Formula (I) that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Type: Grant
Filed: April 19, 2001
Issued: October 7, 2003
Assignee: Syntex (U.S.A.) LLC
Inventors: Soan Cheng, David Michael Goldstein, Teresa Alejandra Trejo Martin, Eric Brian Sjogren
Application number: 20030139462
Abstract: The present invention relates to compounds of Formula (I) 1
Type: Application
Filed: September 17, 2002
Issued: July 24, 2003
Inventors: Soan Cheng, David Michael Goldstein, Teresa Alejandra Trejo Martin, Eric Brian Sjogren
Patent number: 6521594
Abstract: The invention provides cyclic peptides which inhibit platelet aggregation without causing prolonged bleeding time. The invention provides RGD or KGD containing peptides which are cyclized and contain hydrophobic amino acids adjacent to the carboxy terminus of the RGD sequence. Peptides of this nature are also provided which contain in addition to the hydrophobic amino acid an adjacent positively charged amino acid. Such peptides have a high affinity for the receptor IIb/IIIa and a low affinity for the fibronectin and vitronectin receptors. Such peptides can be administered in a suitable physiologically acceptable carrier to therapeutically treat thrombosis.
Type: Grant
Filed: May 22, 1995
Issued: February 18, 2003
Assignee: La Jolla Cancer Research Foundation
Inventors: Michael D. Pierschbacher, Soan Cheng, William S. Craig, Juerg F. Tschopp
Patent number: 6479507
Abstract: The present invention relates to compounds of Formula (I) that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Type: Grant
Filed: April 19, 2001
Issued: November 12, 2002
Assignee: Syntex (U.S.A.) LLC
Inventors: Soan Cheng, David Michael Goldstein, Teresa Alejandra Trejo Martin, Eric Brian Sjogren
1 2 3 next